You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤
In The News
Executives & Employees
Board of Directors

Exosect Ltd.


Date Founded
Leylands Business Park, Colden Common, Winchester, Hampshire So21 1th
Employees (Worldwide)
11 - 50
Commercial Scientific Research

Other Business & Consulting Services

Holding Companies

Consumer Services


Company Description
Exosect Ltd. develops and provides pest management solutions. It enables pesticide manufacturers to improve the delivery of their formulations to overcome pest resistance, regulatory control and residues within the food chain. The firm offers Entostat delivery platform an electro statically charged micro powder that is formulated to microencapsulate synthetic active ingredients and Entomag delivery platform, a ferrous micro powder that enables the particle to be held in place to a suitable magnetic device and used to the targeted delivery of synthetic chemistry particularly for the control of crawling insects in the public health sector. It serves the agriculture, public health and animal health sectors. The company was founded by Philip Harris in 2001 and is headquartered in Winchester, the United Kingdom.

In The News See More

PR Newswire
October 16, 2017

Executives & Employees

Chief Executive Officer

Head-Formulation Development

Chief Administration Officer

Investor Director

Managing Director

Manager-Quality Control & Assurance

Manager-International Business Development
See our list of current and previous employees when you upgrade.

Board of Directors

Co-Founder at WHEB Asset Management LLP

Managing Partner at MTI Partners Ltd.

Co-Founder at Oxford Capital Partners LLP

Co-Founder at Oxford Capital Partners LLP

Investor Director at Exosect Ltd.
See our list of current and previous board members when you upgrade.

Paths to Exosect Ltd.

Exosect Ltd.
Connections via Relationship Science
Exosect Ltd.
Sync your contacts to see how you can connect with Exosect Ltd..


Details Hidden
Hygea vct invests in bioscience companies with a particular focus on investing in treatment development companies. The firm target companies with annual sales greater than £3 million.
Details Hidden
MTI Partners focuses on investments in various sectors such as technology services, health services and energy minerals located in Europe. The firm typically invest in companies which have proven proprietary technology which addresses an identifiable market need, a large potential market and quality management. MTI Partners provides financing for later and early stage capital requirements and it also makes co-investments.
Details Hidden
Clearly Social Angels is angel networking firm with group of high-net-worth individuals and families focused on creating social and environmental impact alongside financial return. The firm invest in technology, retail & products, alternative energy, finance services, suppliers, property and transport startups. The firm invests in seed, early and later stages. It also invested in Public companies. The firm provides fund raising services to clients.
Details Hidden
Chief Administration Officer at Exosect Ltd.
Details Hidden
SAM works closely with the University to enhance development of their intellectual property. Through external partners, they develop spin-out firms, joint ventures and industry-led deals. They draw on the University's areas of expertise and have invested in ventures in oil and gas exploration, pharmaceuticals, nanotechnology and optoelectronics.Actual spin-out firms have been active in areas such as electromagnetic sensing services designed to detect the presence of offshore oil and gas, large-scale project management software, new methods for the synthesis of peptides and proteins, drug evaluation, testing and discovery in CNS disorders, photonic crystal technology, insect pest control solutions, optical solutions via laser wavelength conversion and integrated optical circuit technology, specialty optical fiber, cancer and heart disease drug treatment through histone deacetylase (HDAC) inhibitors, and gamma-ray detector systems.
See 4 more listings with RelSci Professional.

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial
Still not convinced? Check out our full listing of features here.